Variation in plasma fibrinogen over one year: Relationships with genetic polymorphisms and non-genetic factors

Thrombosis and Haemostasis

Volumn 77, Issue 5, 1997, Pages 884-889

  Väisänen, Sari ^a   Rauramaa, Rainer ^a   Penttilä, Ilkka ^b   Rankinen, Tuomo ^a   Gagnon, Jacques ^c   Pérusse, Louis ^c   Chagnon, Monique ^c   Bouchard, Claude ^c  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; RESTRICTION ENDONUCLEASE; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRY; ARTICLE; BODY MASS; CALORIC INTAKE; CARDIOPULMONARY HEMODYNAMICS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; DIET; DNA POLYMORPHISM; ENERGY EXPENDITURE; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; GENE LOCUS; GENETIC POLYMORPHISM; HUMAN; LEUKOCYTE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OXYGEN CONSUMPTION; PHYSICAL ACTIVITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 1842373869     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1656072     Document Type: Article

References (50)

1. Wilhelmsen L, Svärdsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984; 311: 501-5.
2. Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WRS, Haines AP, Stirling Y, Imeson JD, Thompson SG. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; ii: 533-7.
3. Meade TW, Imeson J, Stirling Y. Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease. Lancet 1987; ii: 986-8.
4. Ernst E. Fibrinogen as a cardiovascular risk factor - interrelationship with infections and inflammation. Eur Heart J 1993; 14 (Suppl K): 82-7.
5. Ernst E. The role of fibrinogen as a cardiovascular risk factor. Atherosclerosis 1993; 100: 1-12.
6. Ernst E, Resch KL. The "fibrinogen hypothesis": is elevated plasma fibrinogen a major cardiovascular risk factor? In: Atherosclerosis X. Woodford FP, Davignon J, Sniderman A, eds. Elsevier Science B.V. Amsterdam. 1995; pp 785-92.
7. Folsom AR, Wu KK, Davis CE, Conlan MG, Sorlie PD, Szklo M. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis 1991; 91: 191-205.
8. Stratton JR, Chandler WL, Schwartz RS, Cerqueira MD, Levy WC, Kahn SE, Larson VG, Cain KC, Beard JC, Abrass IB. Effects of physical conditioning on fibrinolytic variables and fibrinogen in young and old healthy adults. Circulation 1991; 83: 1692-7.
9. Elwood PC, Yarnell JWG, Pickering J, Fehily AM, O'Brien JR. Exercise, fibrinogen, and other risk factors for ischaemic heart disease. Caerphilly Prospective Heart Disease Study. Br Heart J 1993; 69: 183-7.
10. Rankinen T, Rauramaa R, Väisänen S, Penttilä I, Saarikoski S, Tuomilehto J, Nissinen A. Inverse relationship between physical activity and plasma fibrinogen in postmenopausal women. Atherosclerosis 1993; 102: 181-6.
11. Hassouna HI. Laboratory evaluation of hemostatic disorders. Hematology/Oncology Clinics of North America: Coagulation Disorders II. 1993; 7: 1161-236.
12. Henschen AH. Human fibrinogen - Structural variants and functional sites. Thromb Haemostas 1993; 70: 42-7.
13. Kant JA, Fornace AJ Jr, Saxe D, Simon MI, McBride OW, Crabtree GR. Evolution and organisation of the fibrinogen locus on chromosome 4: gene duplication accompanied by transposition and inversion. Proc Natl Acad Sci USA 1985; 82: 2344-8.
14. +1689 (AvaII), and BclI (β-fibrinogen) and TaqI (α-fibrinogen), and their detection by PCR. Human Mutation 1994; 3: 79-81.
15. Berg K, Kierulf P. DNA polymorphisms at fibrinogen loci and plasma fibrinogen concentration. Clin Genet 1989; 36: 229-35.
16. Connor JM, Fowkes FGR, Wood J, Smith FB, Donnan PT, Lowe GDO. Genetic variation at fibrinogen loci and plasma fibrinogen levels. J Med Genet 1992; 29: 480-2.
17. Humphries SE, Cook M, Dubowitz M, Stirling Y, Meade TW. Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations. Lancet 1987; i: 1452-5.
18. Green F, Hamsten A, Blombäck M, Humphries S. The role of β-fibrinogen genotype in determining plasma fibrinogen levels in young survivors of myocardial infarction and healthy controls from Sweden. Thromb Haemost 1993; 70: 915-20.
19. Scarabin P-Y, Bara L, Ricard S, Poirier O, Cambou JP, Arveiler D, Luc G, Evans AE, Samama MM, Cambien F. Genetic variation at the β-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction. The ECTIM study. Arterioscler Thromb 1993; 13: 886-91.
20. Humphries SE, Imam AMA, Robbins TP, Cook M, Carritt B, Ingle C, Williamson R. The identification of a DNA polymorphism of the fibrinogen gene and the regional assignment of the human fibrinogen genes to 4q26-qter. Hum Genet 1984; 68: 148-53.
21. Rauramaa R, Väisänen S, Mercuri M, Rankinen T, Penttilä I, Bond MG. Association of risk factors and body iron status to carotid atherosclerosis in middle-aged Eastern Finnish men. Eur Heart J 1994; 15: 1020-7.
22. Rauramaa R, Rankinen T, Tuomainen P, Väisänen S, Mercuri M. Inverse relationship between cardiorespiratory fitness and carotid atherosclerosis. Atherosclerosis 1995; 112: 213-21.
23. Borg GAV. Psychophysiological bases of perceived exertion. Med Sci Sports Exerc 1982; 14: 377-81.
24. Rauramaa R, Tuomainen P, Väisänen S, Rankinen T. Physical activity and health-related fitness in middle-aged men. Med Sci Sports Exerc 1995; 27: 707-12.
25. WHO (World Health Organization). Energy and protein requirements. Report of a joint FAO/WHO/UNU expert consultation. Technical report series 724. World Health Organization, Geneva 1985.
26. Pietinen P, Hartman AM, Haapa E, Räsänen L, Haapakoski J, Palmgren J, Albanes D, Virtamo J, Huttunen JK. Reproducibility and validity of dietary assessment instruments. I. Self-administered food use questionnaire with a portion size picture booklet. Am J Epidemiol 1988; 128: 655-66.
27. Rastas M, Seppänen R, Knuts L-R, Karvetti R-L, Varo P. Nutrient composition of foods. Publications of the Social Insurance Institution, Helsinki, Finland, 1989.
28. Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haemat 1957; 17: 237-46.
29. Penttilä IM, Voutilainen E, Laitinen P, Juutilainen P. Comparison of different analytical and precipitation methods for direct estimation of serum high-density lipoprotein cholesterol. Scand J Clin Lab Invest 1981; 41: 353-60.
30. Pinnell AE, Northam BE. New automated dye-binding method for serum albumin determination with bromcresol purple. Clin Chem 1978; 24: 80-6.
31. The committee of enzymes of the Scandinavian society for clinical chemistry and clinical physiology. Recommended method for the determination of γ-glutamyltransferase in blood. Scand J Clin Lab Invest 1976; 36: 119-25.
32. Sambrook J, Fritsch EF, Maniatis T, eds. Molecular cloning: A laboratory manual. Cold Spring Harbor Laboratory Press 1989, pp 9.16-9.19.
33. Zar JH. Biostatistical analysis. 2nd ed. Englewood Cliffs: Prentice-Hall, 1984, pp 313-4.
34. Iso H, Folsom AR, Winkelmann JC, Koike K, Harada S, Greenberg B, Sato S, Shimamoto T, Iida M, Komachi Y. Polymorphisms of the beta fibrinogen gene and plasma fibrinogen concentration in Caucasian and Japanese population samples. Thromb Haemost 1995; 73: 106-11.
35. Thomas AE, Green FR, Kelleher CH, Wilkes HC, Brennan PJ, Meade TW, Humphries SE. Variation in the promoter region of the β-fibrinogen gene is associated with plasma fibrinogen levels in smokers and non-smokers. Thromb Haemost 1991; 65: 487-90.
36. de Maat MPM, de Knijff P, Green FR, Thomas AE, Jespersen J, Kluft C. Gender-related association between β-fibrinogen genotype and plasma fibrinogen levels and linkage disequilibrium at the fibrinogen locus in Greenland Inuit. Arterioscler Thromb Vasc Biol 1995; 15: 856-60.
37. -455-A β-gene) is associated with differences in plasma fibrinogen levels in young men and women from different regions in Europe. Evidence for gender-genotype-environment interaction. Arterioscler Thromb Vasc Biol 1995; 15: 96-104.
38. Behague I, Poirier O, Nicaud V, Evans A, Arveiler D, Luc G, Cambou J-P, Scarabin P-Y, Bara L, Green F, Gambien F. β fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM study. Circulation 1996; 93: 440-9.
39. Friedlander Y, Elkana Y, Sinnreich R, Kark JD. Genetic and environmental sources of fibrinogen variability in Israeli families: The Kibbutzim family Study. Am J Hum Genet 1995; 56: 1194-206.
40. Rosenson RS, Tangney CC, Hafner JM. Intraindividual variability of fibrinogen levels and cardiovascular risk profile. Arterioscler Thromb 1994; 14: 1928-32.
41. Chambless LE, McMahon R, Wu K, Folsom A, Finch A, Shen Y-L. Short-term intraindividual variability in hemostasis factors: the ARIC study. Ann Epidemiol 1992; 2: 723-33.
42. Marckmann P, Sandström B, Jespersen J. The variability of and associations between measures of blood coagulation, fibrinolysis and blood lipids. Atherosclerosis 1992; 96: 235-44.
43. Wilkes HC, Kelleher C, Meade TW. Smoking and plasma fibrinogen. Lancet 1988; i: 307-8.
44. Yarnell JWG, Sweetnam PM, Rogers S, Elwood PC, Bainton D, Baker IA, Eastham R, O'Brian JR, Etherington MR. Some long term effects of smoking on the haemostatic system: A report from the Caerphilly and Speedwell Collaborative Surveys. J Clin Pathol 1987; 40: 909-13.
45. Ernst E, Matrai A. Abstention from chronic cigarette smoking normalizes blood rheology. Atherosclerosis 1987; 64: 75-7.
46. Yarnell JWG, Baker IA, Sweetnam PM, Bainton D, O'Brien JR, Whitehead PJ, Elwood PC. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies. Circulation 1991; 83: 836-44.
47. Patel P, Mendall MA, Carrington D, Strachan DP, Leatham E, Molineaux N, Levy J, Blakeston C, Seymour CA, Camm AJ, Northfield TC. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ 1995; 311: 711-4.
48. Sakata Y, Morimoto A, Long NC, Murakami N. Fever and acute-phase response induced in rabbits by intravenous and intracerebroventricular injection of interleukin-6. Cytokine 1991; 3: 199-203.
49. Conti P, Bartle L, Barbacane RC, Reale M, Sipe JD. The down-regulation of IL-6-stimulated fibrinogen steady state mRNA and protein levels by human recombinant IL-1 is not PGE2-dependent: Effects of IL-1 receptor antagonist (IL-1RA). Mol Cell Biochem 1995; 142: 171-8.
50. Rankinen T, Rauramaa R, Väisänen S, Penttilä I, Uusitupa M. Relation of habitual diet and cardiorespiratory fitness to blood coagulation and fibrinolytic factors. Thromb Haemost 1994; 71: 180-3.